Search by Drug Name or NDC

    NDC 11822-3317-00 Maxi Nicotine 4 mg/1 Details

    Maxi Nicotine 4 mg/1

    Maxi Nicotine is a ORAL LOZENGE in the HUMAN OTC DRUG category. It is labeled and distributed by Rite Aid Corporation. The primary component is NICOTINE.

    Product Information

    NDC 11822-3317
    Product ID 11822-3317_ed25aa6c-4135-4f85-af0b-fea22d07e1e7
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Maxi Nicotine
    Proprietary Name Suffix n/a
    Non-Proprietary Name nicotine polacrilex
    Product Type HUMAN OTC DRUG
    Dosage Form LOZENGE
    Route ORAL
    Active Ingredient Strength 4
    Active Ingredient Units mg/1
    Substance Name NICOTINE
    Labeler Name Rite Aid Corporation
    Pharmaceutical Class Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA209206
    Listing Certified Through 2024-12-31

    Package

    NDC 11822-3317-00 (11822331700)

    NDC Package Code 11822-3317-0
    Billing NDC 11822331700
    Package 4 BOTTLE, PLASTIC in 1 BOX (11822-3317-0) / 27 LOZENGE in 1 BOTTLE, PLASTIC
    Marketing Start Date 2019-11-29
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 1472b0a3-5ff1-44e7-8748-a3b1a5e55196 Details

    Revised: 1/2022